ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

Overview of attention for article published in Trials, April 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 news story.

This Reading Room is a collaboration between MedPage Today® and: In metastatic urothelial cancer (mUC), characterization of the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.